תוצאות חיפוש - David I. Marks
- Showing 1 - 20 results of 97
- Go to Next Page
-
1
Management of adults with T-cell lymphoblastic leukemia מאת David I. Marks, Clare Rowntree
יצא לאור 2017Revisão -
2
Patient‐reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia מאת Hagop M. Kantarjian, Yun Su, Elias Jabbour, Helen Bhattacharyya, Eric Yan, Joseph C. Cappelleri, David I. Marks
יצא לאור 2018Artigo -
3
-
4
-
5
Management of important adverse events associated with inotuzumab ozogamicin: expert panel review מאת Partow Kebriaei, Corey Cutler, Marcos de Lima, Sergio Giralt, Stephanie J. Lee, David I. Marks, Akil Merchant, Wendy Stock, Koen van Besien, Matthias Stelljes
יצא לאור 2018Artigo -
6
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation מאת David I. Marks, Antonio Pagliuca, Christopher C. Kibbler, Axel Glasmacher, Claus Peter Heußel, Michal Kantecki, Paul Miller, Patricia Ribaud, Haran T. Schlamm, Carlos Solano, Gordon Cook
יצא לאור 2011Artigo -
7
Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committ... מאת Joseph Bubalo, Paul A. Carpenter, Navneet S. Majhail, Miguel‐Angel Perales, David I. Marks, Paul Shaughnessy, Joseph Pidala, Helen Leather, John R. Wingard, Bipin N. Savani
יצא לאור 2014Revisão -
8
The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation מאת Rhian Fuge, Jennifer M. Bird, Anne Fraser, Dan Hart, Linda Hunt, Jacqueline Cornish, Nicholas Goulden, A Oakhill, Derwood Pamphilon, Colin G. Steward, David I. Marks
יצא לאור 2001Artigo -
9
Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Bl... מאת Gordon Cook, Graeme Smith, Keiren Kirkland, Jungwha Lee, Rachel Pearce, Kirsty Thomson, Emma Morris, Kim Orchard, Simon Rule, Nigel H. Russell, Charles Craddock, David I. Marks
יצא לאור 2010Artigo -
10
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study מאת Julio Delgado, Kirsty Thomson, Nigel H. Russell, Joanne Ewing, Wendy A. Stewart, Gordon Cook, Stephen Devereux, Richard Lovell, Rajesh Chopra, David I. Marks, Stephen Mackinnon, Donald Milligan
יצא לאור 2005Artigo -
11
Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantatio... מאת Gordon Cook, Effie Liakopoulou, Rachel Pearce, Jim Cavet, Gareth J. Morgan, Keiren Kirkland, Julia Lee, Faith E. Davies, R. Hall, Amin Rahemtulla, Nigel H. Russell, David I. Marks
יצא לאור 2011Artigo -
12
Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro מאת Juliana Redondo, Pamela Sarkar, Kevin Kemp, Paul Virgo, Joya Pawade, Aimie Norton, David C. Emery, M.G. Guttridge, David I. Marks, Alastair Wilkins, Neil Scolding, Claire M Rice
יצא לאור 2017Artigo -
13
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease מאת Partow Kebriaei, Jack Hayes, Andrew Daly, Joseph P. Uberti, David I. Marks, Robert J. Soiffer, Edmund K. Waller, Elizabeth Burke, Donna Skerrett, Elizabeth J. Shpall, Paul J. Martin
יצא לאור 2019Artigo -
14
Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hem... מאת Muhammad Bilal Abid, Noel Estrada-Merly, Mei‐Jie Zhang, Karen Chen, Christopher Bredeson, David Allan, Mitchell Sabloff, David I. Marks, Mark R. Litzow, Christopher S. Hourigan, Partow Kebriaei, Wael Saber
יצא לאור 2023Artigo -
15
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia מאת Judith Marsh, Vikas Gupta, ZiYi Lim, Aloysius Ho, Robin Ireland, Janet Hayden, Victoria Potter, Mickey Koh, M. Serajul Islam, Nigel H. Russell, David I. Marks, Ghulam J. Mufti, Antonio Pagliuca
יצא לאור 2011Artigo -
16
Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden מאת Daniel J. DeAngelo, Anjali S. Advani, David I. Marks, Matthias Stelljes, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Elias Jabbour, Akil Merchant, Tao Wang, Erik Vandendries, Alexander Neuhof, Hagop M. Kantarjian, Susan O’Brien
יצא לאור 2020Artigo -
17
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia מאת David I. Marks, Partow Kebriaei, Matthias Stelljes, Nicola Gökbuget, Hagop M. Kantarjian, Anjali S. Advani, Akil Merchant, Wendy Stock, Ryan D. Cassaday, Tao Wang, Hui Zhang, Fausto R. Loberiza, Erik Vandendries, Daniel J. DeAngelo
יצא לאור 2019Artigo -
18
Outcomes in older adults with acute lymphoblastic leukaemia (<scp>ALL</scp>): results from the international <scp>MRC UKALL XII</scp>/<scp>ECOG</scp>2993 trial מאת Jonathan Sive, Georgina Buck, Adele K. Fielding, Hillard M. Lazarus, Mark R. Litzow, Selina M. Luger, David I. Marks, Andrew McMillan, Anthony V. Moorman, Susan Richards, Jacob M. Rowe, Martin S. Tallman, Anthony H. Goldstone
יצא לאור 2012Artigo -
19
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant reci... מאת Eric J. Bow, David J. Vanness, Monica A. Slavin, Catherine Cordonnier, Oliver A. Cornely, David I. Marks, Antonio Pagliuca, Carlos Solano, Lael Cragin, A. Shaul, Sonja Sorensen, Richard Chambers, Michal Kantecki, David Weinstein, Haran T. Schlamm
יצא לאור 2015Revisão -
20
Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies מאת Robert J. Soiffer, Jennifer Le‐Rademacher, Vincent T. Ho, Fangyu Kan, Andrew Artz, Richard E. Champlin, Steven M. Devine, Luis Isola, Hillard M. Lazarus, David I. Marks, David Porter, Edmund K. Waller, Mary M. Horowitz, Mary Eapen
יצא לאור 2011Artigo
כלי חיפוש:
נושאים קשורים
Medicine
Internal medicine
Transplantation
Hematopoietic stem cell transplantation
Oncology
Leukemia
Surgery
Biology
Gastroenterology
Immunology
Chemotherapy
Genetics
Stem cell
Confidence interval
Physics
Haematopoiesis
Hematopoietic cell
Bone marrow
Lymphoblastic Leukemia
Cyclophosphamide
Hazard ratio
Incidence (geometry)
Myeloid leukemia
Optics
Acute leukemia
Cumulative incidence
Lymphoma
Intensive care medicine
Graft-versus-host disease
Acute lymphocytic leukemia